Designed to prevent and protect against Benign Prostate Hyperplasia, which affects millions of men worldwideCHICAGO, IL / ACCESSWIRE / March…
Named Patient Program (NPP) enables physicians to prescribe the Company's novel Mazindol Extended-Release (ER) formulation to patients who have failed…
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESVANCOUVER, BC / ACCESSWIRE / March…
BEIJING, March 28, 2022 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”; NASDAQ: SISI), a producer and distributor of…
New York, New York--(Newsfile Corp. - March 28, 2022) - Plantable® Health Inc. (NEO: PLBL) ("Plantable" or the "Company"), a…
First patient dosed in Phase III clinical trial for PET radiopharmaceutical Next stage clinical study also proceeding for SPECT radiopharmaceutical…
Companies Recognized for Medical Billing, Patient Engagement, and Patient Scheduling IRVINE, Calif.--(BUSINESS WIRE)--#Kareo--Kareo, the leading provider of cloud-based clinical and…
LONDON, UK / ACCESSWIRE / March 28, 2022 / Nanomerics Ltd., a private speciality pharmaceutical company, today announced that the…
STOCKHOLM, SWEDEN / ACCESSWIRE / March 28, 2022 / iZafe Group (STO:IZAFE-B)iZafe Group (publ.) hereby announces that the partner Hepro…
Relief Therapeutics' Wholly Owned Subsidiary, APR Applied Pharma Research, Reports In Vivo Data Published in the Peer Reviewed, International Journal…